Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Madeira, Hugo"'
Autor:
Mendonça, Carlota, de Macedo, Diana, Nicolai, Carlos, Madeira, Hugo, Van Dooren, Eric, Norré, David, Mata, António
Publikováno v:
International Journal of Prosthodontics; 2024, Vol. 37 Issue 4, p394-403, 10p
Autor:
Brito, Dulce, Cardim, Nuno, Lopes, Luís Rocha, Belo, Adriana, Mimoso, Jorge, Gonçalves, Lino, Madeira, Hugo
Publikováno v:
In Revista Portuguesa de Cardiologia June 2018 37(6):457-466
Autor:
Cardim, Nuno, Brito, Dulce, Rocha Lopes, Luís, Freitas, António, Araújo, Carla, Belo, Adriana, Gonçalves, Lino, Mimoso, Jorge, Olivotto, Iacopo, Elliott, Perry, Madeira, Hugo
Publikováno v:
In Revista Portuguesa de Cardiologia January 2018 37(1):1-10
Publikováno v:
In The American Journal of Cardiology 1 October 2013 112(7):996-1004
Autor:
Brito, Dulce, Miltenberger-Miltenyi, Gabriel, Vale Pereira, Sónia, Silva, Doroteia, Diogo, António Nunes, Madeira, Hugo
Publikováno v:
In Revista Portuguesa de Cardiologia September 2012 31(9):577-587
Autor:
Velavan, Periaswamy, Khan, Nasrin K., Goode, Kevin, Rigby, Alan S., Loh, Poay H., Komajda, Michel, Follath, Ferenc, Swedberg, Karl, Madeira, Hugo, Cleland, John G.F.
Publikováno v:
In International Journal of Cardiology 2010 138(1):63-69
Autor:
Santos Susana, Marques Vanda, Pires Marina, Silveira Leonor, Oliveira Helena, Lança Vasco, Brito Dulce, Madeira Hugo, Esteves J Fonseca, Freitas António, Carreira Isabel M, Gaspar Isabel M, Monteiro Carolino, Fernandes Alexandra R
Publikováno v:
BMC Medical Genetics, Vol 13, Iss 1, p 17 (2012)
Abstract Background Hypertrophic Cardiomyopathy (HCM) is a complex myocardial disorder with a recognized genetic heterogeneity. The elevated number of genes and mutations involved in HCM limits a gene-based diagnosis that should be considered of most
Externí odkaz:
https://doaj.org/article/188b1051ec1d4ddaaa71868795b49681
Autor:
Brito, Dulce, Cardim, Nuno, Lopes, Luís Rocha, Belo, Adriana, Mimoso, Jorge, Gonçalves, Lino, Madeira, Hugo
Copyright © 2018 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved. INTRODUCTION: In adults, unexplained left ventricular hypertrophy is usually due to sarcomeric hypertrophic cardiomyopathy (HCM). Fabry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1437::4f8f4c47d0ad43719330c28798d3aa91
https://hdl.handle.net/10362/148265
https://hdl.handle.net/10362/148265
Autor:
Cardim, Nuno, Brito, Dulce, Rocha Lopes, Luís, Freitas, António, Araújo, Carla, Belo, Adriana, Gonçalves, Lino, Mimoso, Jorge, Olivotto, Iacopo, Elliott, Perry, Madeira, Hugo
Funding Information: Gold: Jaba Recordati, Merck Serono, Sanofi-Genzyme, Shire; Silver: Medinfar, Servier IOi was supported by the Italian Ministry of Health (“LVH in aortic valve disease and HCM: genetic basis, biophysical correlates and viral the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1437::a804cbfa7c7d2fdd15f65fae0dd7ebf8
https://hdl.handle.net/10362/147561
https://hdl.handle.net/10362/147561
Autor:
Villard, Eric, Perret, Claire, Gary, Françoise, Proust, Carole, Dilanian, Gilles, Hengstenberg, Christian, Ruppert, Volker, Arbustini, Eloisa, Wichter, Thomas, Germain, Marine, Dubourg, Olivier, Tavazzi, Luigi, Aumont, Marie-Claude, Degroote, Pascal, Fauchier, Laurent, Trochu, Jean-Noël, Gibelin, Pierre, Aupetit, Jean-François, Stark, Klaus, Erdmann, Jeanette, Hetzer, Roland, Roberts, Angharad, Barton, Paul J.R., Regitz-Zagrosek, Vera, Aslam, Uzma, Duboscq-Bidot, Laëtitia, Meyborg, Matthias, Maisch, Bernhard, Madeira, Hugo, Waldenström, Anders, Galve, Enrique, Cleland, John, Dorent, Richard, Roizes, Gerard, Zeller, Tanja, Blankenberg, Stefan, Goodall, Alison, Cook, Stuart, Tregouet, David, Tiret, Laurence, Isnard, Richard, Komajda, Michel, Charron, Philippe, Cambien, François, Gorin, Laurent, Nonin, Emilie, Charbonnier, Bernard, Babuty, Dominique, Lip, Gregory Y.H.
Publikováno v:
Chest
Chest, 2011, 140 (4), pp.911-917. ⟨10.1378/chest.10-2436⟩
Chest, 2011, 140 (4), pp.911-917. ⟨10.1378/chest.10-2436⟩
Background In patients with atrial fibrillation (AF), adherence to guidelines for antithrombotic treatment is poorly followed, and undertreatment (or nonadherence with guidelines) is associated with a worse prognosis. The study objective was to evalu